AstraZeneca Just Sold Its Moderna Stock: Should You?

AstraZeneca Just Sold Its Moderna Stock: Should You?

Earlier this week, British newspaper The Times reported that AstraZeneca (NASDAQ: AZN) sold its entire stake in Moderna (NASDAQ: MRNA). Should other investors following AstraZeneca's lead and sell Moderna stock too? AstraZeneca first invested in Moderna in 2013, more than five years before the biotech conducted its initial public offering (IPO).